Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship

This study focuses on the long-term and delayed adverse events associated with chemotherapy and other anticancer treatments, which have significant implications for patients' survival, quality of life, and treatment continuation. The study emphasizes the lack of systematic efforts in evaluating the effectiveness of interventions to mitigate these adverse events. The study highlights the biological mechanisms underlying these effects, along with pharmacological and non-pharmacological treatment strategies and clinical guidelines for managing them. The study also covers risk factors and tools for identifying patients who may benefit from interventions and explores emerging supportive care options for cancer survivors at risk of treatment-related complications.